----
Current ValuationThe current P/E ratio is 14.44, within the reasonable range, cheaper than 41.76% of the time in the past 1 years, and the industry ranks 7/174, the industry Median -0.89.
14.44xP/E
$67.45Stock price
$4.67Earnings per share
14.44xP/E
Stock price$67.45Earnings per share$4.67
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 12.83x
- Typical range
- 10.54x–54.66x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
012243648
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
GEHCUSGE HealthCare Tech | 14.72x | 2.63% | $29.21B |
INSPUSInspire Medical | 14.44x | 100.86% | $1.95B |
INMDUSInMode | 10.40x | 21.54% | $806.19M |
PDEXUSPro-Dex | 14.72x | 25.00% | $201.17M |
KEQUUSKewaunee Scientific | 11.90x | -- | $97.98M |
LNSRUSLensar - W/I | 5.44x | 129.62% | $79.98M |
DXRUSDaxor | 9.85x | 111.42% | $61.36M |
SNWVUSSANUWAVE Health | 3.12x | 119.51% | $47.66M |
ZJYLUSJin Medical | 14.15x | -- | $16.59M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
